Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

Herbomineral drugs effectively manage chemotherapy-induced diarrhea in oral cavity cancer patients.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

New, safer, and personalized treatments are needed for oral lichen planus.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Iron supplements help reduce fatigue in anaemia but often cause side effects like black stools and stomach issues.

Late dumping syndrome after fundoplication can be diagnosed with an oral glucose tolerance test and managed with diet changes.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

MK-5108 is safe and shows potential against tumors, especially alone.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.